Clinical Trial Update: A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating paclitaxel plus bevacizumab in chemosensitive relapsed small cell lung cancer. The study is spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED